2 edition of Lobar pneumonia and serum therapy found in the catalog.
Lobar pneumonia and serum therapy
Frederick Taylor Lord
by The Commonwealth fund; London, H. Milford, Oxford university press in New York
Written in English
|Statement||[by] Frederick T. Lord ... [and] Roderick Heffron ...|
|Contributions||Heffron, Roderick, 1901-|
|LC Classifications||RC771 .L58 1936a|
|The Physical Object|
|Pagination||5 p. l., 91 p.|
|Number of Pages||91|
|LC Control Number||36008602|
THE SERUM TREATMENT OF THE SERUM TREATMENT OF LOBAR PNEUMONIA; Articles THE SERUM TREATMENT OF LOBAR PNEUMONIA. A REPORT OF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL. Br Med J ; BibTeX (win & mac)Download; EndNote (tagged)Download;. Typical symptoms of lobar pneumonia include fever, chills, cough productive of mucopurulent sputum, and pleuritic chest absence of fever and mucopurulent sputum makes pneumonia an unlikely diagnosis.. CAP caused by Legionella is commonly associated with high fever (above 40° C), multilobar involvement, male sex, neurologic and gastrointestinal sequelae.
Additional Physical Format: Online version: Avery, Oswald Theodore, Acute lobar pneumonia (OCoLC) Document Type: Book: All Authors / Contributors. During the two winter seasons , , a total of cases of lobar pneumonia between the ages of 20 and 60 years were studied in Aberdeen, Edinburgh and London as part of an organized investigation into the value of antipneumococcal serum. Of these, belonged to Type I or Type II, and were treated with serum. In an independent enquiry in Glasgow cases aged 20 to 60 years.
Park et al. compared serotherapy with standard treatment for patients with lobar pneumonia at Harlem Hospital from to As discussed for similar studies noted above, this study is of limited value for quantifying the treatment effect of serum by: Pneumonia: Symptoms, Types, and Treatment For Pneumonia All over the world, pneumonia has been accounted for the deaths of , children. It is therefore important to better understand the disease in able to prevent these numbers from increasing continuously/5(4).
Fiscal years 1986-1993 projections
Safety by objectives, SBO
De Lees Obstetrics for nurses.
Tenth-grade WASL in spring 2006
agricultural development of the Middle East
A rendezvous in Haiti
A new graded method in English grammar
world in the air
Phase I report
community development approach for project proposals & programmes (CDA PPP)
The friendly classroom for a small planet
Failure mechanisms during isothermal fatigue of SiC/Ti-24Al-11Nb composites
Cochineal and the insect dyes
Alphabet book of over two hundred type faces.
When Daddy Came Home
Acute Lobar Pneumonia; Prevention and Serum Treatment [Theodore, Avery Oswald] on *FREE* shipping on qualifying offers. Unlike some other reproductions of classic texts (1) We have not used OCR(Optical Character Recognition).
Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (K), or click on a page image below to browse page by by: 7. "Lobar Pneumonia and Serum Therapy." American Journal of Public Health and the Nations Health, 26(4), p.
Author: Mazÿck P. Ravenel. This small volume presents in a simple and concise manner the value and technic of serum therapy in pneumonia. The immunologic and bacteriologic aspects of the disease are discussed in the light of recent developments.
Both authors have been intimately connected with the study of pneumonia. TREATMENT OF LOBAR PNEUMONIA BY FELTON'S SERUM John Cowan A.W.
Harrington Robert Cruickshank D.P. Cuthbertson John Fleming (From the Royal Infirmary, Glasgow), United Kingdom FOR the last two years we have had at our disposal a supply of Felton's serum Cited by: Original Article from The New England Journal of Medicine — The Serum Treatment of Lobar PneumoniaCited by: Tms paper records results obtained by treating patients suffering from lobar pneumonia with the polyvalent serum made by the Lister Institute.
As soon as the diagnosis was made, and opportunity offered, the patient was given antipneumococcal serum either subcutaneously or by: 4.
Acute lobar pneumonia; prevention and serum treatment Item Preview remove-circle Follow the "All Files: HTTP" link in the "View the book" box to the left to find XML files that contain more metadata about the original images and the derived formats (OCR results, PDF etc.).Pages: PHYSICIAN, HOPE HOSPITAL L.
Stent M.D. Manch., Dipl. Bact. ASSISTANT PATHOLOGIST, CITY OF SALFORD THE published results of serum therapy in lobar pneumonia in this country have been based on comparatively small numbers, so that observations on yet another modest series will add to the accumulat- ing knowledge of the subject and help to form the basis of a critical by: 2.
Lobar pneumonia is typically acute with four stages: Congestion — Within the first 24 hours the patient will develop vascular engorgement (the lung becomes heavy and hyperemic).; Consolidation (red hepatization) — The vascular congestion persists.
There is extravasation of red cells in the alveolar spaces. This leads to the appearance of consolidation (solidification) of the alveolar Missing: serum therapy. Lobar Pneumonia and Serum Therapy: With Special Reference to the Massachusetts Pneumonia Study.
The Indian Medical Gazette, 01 Sep71(9):. Such, however, has not been the case in the treatment of pneumonia. Apparently the recent interest in the serum treatment of lobar pneumonia has expressed itself in so many forms, other than in curing patients, that one may well ask questions about merit and : M.
Blankenhorn. This small book, written with special reference to the experience of the Massachusetts Pneumonia Study, will be of interest and value to all those engaged in the care of pneumonia cases. Every M LORD DAWSON: TREATMENT OF LOBAR PNEUMONIA. clinician must often have said to himself, [quot] If only this visitation could be shortened, even by one day.
[quot] And now we find that the average day of the crisis of the disease is brought nearer, to the sixth day, by the use of Felton's serum, in Type I-a very con- siderable gain. Cecil Russell L. and W D. Sutliff, “The Treatment of Lobar Pneumonia With Concentrated Antipneumococcus Serum,” Journal of the American Medical Association 91 (): –; William H.
Park, Jesse G. Bullowa, and Milton B. Rosenblüth, “The Treatment of Lobar Pneumonia With Refined Specific Antibacterial Serum,” Journal of the Cited by: 7. The adoption of a unit for measurement.,of protective power of sera has also contributed to THE SERUM TREATMENT OF PNEUMONIA I standardizing dosage, which is regularly expressed in units per dose.
The average initial dose is f to 60, Author: W.S. Tillett. FEB. 10, ] SERUMTREATMENTOFLOBARPNEUMONIA r THEBRITISH LMEDICALJOURNAL THE SERUM TREATMENT OF LOBAR PNEUMONIA AREPORTOF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL During the last three years the Mledical Research Council have assisted an inquiry at different centres in Great Britain into the therapeutic value of specific sera for lobar pneumonia.
Typical bacterial pneumonia is usually lobar pneumonia with para-pneumonic pleural effusions. However, a chest x-ray cannot reliably differentiate bacterial from a non-bacterial cause.
When the labs and clinical features are positive, a positive chest radiograph is considered a gold standard for diagnosis of : Parul Pahal, Sandeep Sharma. One learns of the expected results of the modern treatment of pneumonia.
In Massachusetts during the last five years, patients with pneumonia, infected with type I or type II Pneumococcus, whose condition was recognized early and who received serum as quickly as possible fared well, on the whole.
TREATMENT OF LOBAR PNEUMONIA BY ANTI-PNEUMOCOCCAL SERUM BY RICHARD R. ARMSTRONG, M.D., F.R.C.P. AND R. SLEIGH JOHNSON, M.D., M.R.C.P. The results of a preliminary study of twenty-six cases of lobar pneumonia, treated with concentrated anti-pneumo coccal serum during the winter ofhave been published already,1 and the account which.
Get this from a library! Lobar pneumonia and serum therapy, with special reference to the Massachusetts pneumonia study. [Frederick Taylor Lord; Roderick Heffron]. The use of serum therapy wouldsoon be eliminated after the introduction of sulfonamides in While the principal therapeutic option for the treatment of pneumonia prior to was serum therapy, a potential alternative to this therapeutic monopoly was emergingduring the s in the form of by: Download PDF: Sorry, we are unable to provide the full text but you may find it at the following location(s): g (external link)Author: Mazÿck P.